Vaccines & delivery devices

All topics related to vaccine products, presentation and packaging; also includes temperature indicators such as vaccine vial monitors (VVMs) and vaccine delivery devices.

Posts

On March 1, 2024, HLN released a new version (v1.42.1) of the Immunization Calculation Engine (ICE). ICE is a state-of-the-art open source software system that provides clinical decision support for immunizations for use in Immunization Information Systems (IIS), Electronic Health Record (EHR), and ...
Invitation to participate in prioritization of HPV vaccine implementation research questions survey. In all regions of the world, HPV vaccination coverage remains stubbornly low in many countries.  Globally, the average first HPV dose coverage was only 59% in 2022. This coverage is far below the 90...
  These advancements in technology in vaccine and cold chain have caught the attention of various stakeholders in the private and public sector, including the Ministry of Health in different countries and both local and global partners involved in immunization. As a result, they have invested ...
On November 6, 2023, HLN released a new version (v1.41.1) of the Immunization Calculation Engine (ICE) to several vaccine groups. ICE is a state-of-the-art open source software system that provides clinical decision support for immunizations for use in Immunization Information Systems (IIS), Electro...
Hi colleagues, Wanted to know if same MR vaccine can be used both for children and adults. Thank you all in advance for your kind advice. ...
During my service delivery of house to house polio immunization for babies. Some parent will refuse their babies been vaccinated, saying that is against religious belief. Do you have any advice to share? ...
Greetings everyone, I have a query regarding the storage of OPV (Oral Polio Vaccine). If I were to store OPV in a freezer with temperatures ranging from -15 to -25 degrees Celsius, but it gets exposed to higher temperatures of -8 to -10 degrees Celsius during power outages, I'm curious about the fo...
The Gavi Zero-Dose Learning Hub (ZDLH), led by JSI Research & Training Institute, Inc., is pleased to announce the publication of a case study describing the introduction of the typhoid conjugate vaccine (TCV) in Nepal. The case study highlights innovative approaches that successfully identified...
The importance of immunization for child survival underscores the need to eliminate immunization inequalities. Few existing studies of inequalities use approaches that view the challenges and potential solutions from the perspective of caregivers. The USAID MOMENTUM Routine Immunization Transformati...
The Vaccine Innovation Prioritisation Strategy (VIPS) is a collaboration between the Gavi Secretariat, World Health Organization (WHO), Bill & Melinda Gates Foundation (BMGF), United Nations Children’s Fund (UNICEF) and PATH to evaluate and prioritize vaccine product innovations for low- and l...
PATH is excited to announce the 7th International Conference on Microneedles will be held May 15 through 17, 2023, in Seattle, Washington. This in-person conference will bring together researchers, scientists, public health leaders, and industry experts from across the globe focused...
A request for information from colleagues on this forum who are closer to the field than I currently am--- Several months ago I saw UNICEF, PATH and others warning about impending syringe shortages because of Covid vaccines. Looking at the numbers, it does seem very likely that this will indeed be ...
  Considérant que le vaccin contre la rubéole est souvent combiné à d'autres vaccins, le cas du vaccin ROR (Rougeole Oreillons Rubéole) Considérant les effets néfastes de la rubéole chez la femme enceinte, particulièrement au premier trimestre de la grossesse (mort in utero, fosses couches, m...
Register now to join thought leaders from GSK, ISGlobal, Oxford University, PATH, Sanaria, WHO, and other institutions in a discussion of: Lessons Learned from a Vaccine without a Dual Market -- from RTS,S Research and Development to Implementation and Distribution Future Malaria Vaccine R&D...
Dear colleagues, Respiratory Syncytial Virus (RSV) is a common cause of childhood acute lower respiratory infection that leads to hospitalizations and deaths, particularly in children younger than 6 months. Product development efforts are underway to make available a monoclonal antibody (mAb) tha...
Speakers for the GVIRF Webinar on October 14 will include  Allison August, Moderna Ulrich Blaschke, BioNTech Pieter Cullis, University of British Columbia Martin Friede, WHO Philippe-Alexandre Gilbert, BMGF Lee Hall, NIAID Parasitology and International Programs Vivian Hsu, BMGF Holge...
I am delighted to share with you the attached case study for Data4Action Training and Community Platform, we have developed this platform for UNICEF MENA regional office to support countries to conduct data collection projects and country assessments in various topics. See attached file. ...
Register now for the first GVIRF Webinar, on October 14, 2021. Topics will include:  Current status of mRNA vaccine development and manufacturing Extending mRNA vaccines to other global health challenges mRNA manufacturing for low- and middle-income countries Emerging RNA technologies ...
Dear Friends,                       There is an acute shortage of Covid -19 vaccines in India & developing countries. Intradermal use of COVID 19 Vaccines will result in saving up to four fifth (80%) volume of vaccines-i.e. up to five ...
Description: PATH’s Living Labs Initiative used human-centered design methods to gather feedback on proposed labels for COVID-19 vaccine vials and cartons. Healthcare workers in Kenya and Zambia interacted with the labels and made recommendations for vaccine manufacturers for labels for future ...
If a recipient received Influenza (Flu) Vaccine can receive COVID19 Vaccine next day more precisely AstraZeneca...
Dear experts This idea was presented in this forum more than one year ago, this week the NY Times wrote: "Biden’s Support for Vaccine Patent Waivers Faces Uphill Effort in Europe". It will be achieved? Will three million of deaths not serve to take the decision? We will have vaccines for the peopl...
The Single-dose HPV Vaccine Evaluation Consortium collates and synthesizes existing evidence and evaluates new data on the potential for single-dose HPV vaccination. Their goal is to inform global policy discussions and program guidance, as well as to raise awareness and understanding of its implica...
HLN Consulting has released a hosted solution to support vaccine providers with registration capabilities to comply with the CDC’s COVID-19 vaccination provider agreement requirements HLN Consulting has just released a critical application to help complete the CDC’s COVID-19 vaccination provider ag...
The Access to COVID-19 Tools (ACT) Accelerator's Country Readiness and Delivery workstream  is developing COVID-19 vaccine specific training resources.  COVID-19 vaccine explainers are designed to support countries in preparing for specific requirements presented by each vaccine product t...
Today, DHIS2 released two new components of the DHIS2 COVID-19 Vaccine Delivery Toolkit that are now available to download and install: Electronic Immunization Registry (EIR) (tracker / case-based data) Vaccination Core Analysis & Datasets (aggregate) These metadata packages are...
Hello everyone! Im Charisse Tan from Philippines. I would like to know if there are official publication or established SUSAR for any of the covid-19 vaccine? What is the difference between SUSAR and serious AEFI? Thank you :)...
 Dear all, I am looking for sampling in EVM 2. Please help me know the sampling process , sampling frame ....
I wish to add to the very practical and sensible Robin and Rafael discussions on Covid-19. There should be more specific stability data provided for the candidate vaccines. ULT is really a non-reality for logistics in terms of cost and maintenance for LMIC countries for a country wide pandemic (vers...
Many thanks for attending the session on measles and rubella microarray patches. Follow the URL below to see the session in case you have missed it:  https://www.youtube.com/watch?v=wAcQx5SI6c8 Below I summarise key discussion points from the session:  • The few remaining countries that...
Greetings, everyone. I hope that you are healthy and keeping your spirits up amidst these trying times. In March this year, just before COVID-19 shutdowns, I visited health facilities in Kinshasa - where mothers were being asked to wait (one for over 2 hours) and turned away for measles vaccination...
As part of the fourth cohort of the WHO GRISP Scholar course, WHO warmly invites you to two open Special Events on routine immunization: 1. Gender and Routine Immunization, Wednesday 14h (2pm) September 23 Geneva time 2. Strategies for catch-up vaccination in the context of COVID-19, Wednesday 14h...
Hello everyone, I'm a design engineering student working on designing and producing a new powered vaccine carrier, and I was hoping to get some information and feedback from those of you who are out in the field providing immunisations and delivering vaccines to remote communities.  I'm also ...
The challenge before us is an enormous one – many lives hang in the balance. But never in the history of the world have we had as many resources available to craft solutions as we do today. When a Covid-19 vaccination is developed, we have the benefit of innovative homegrown tech that already exists...
Dear Technet community, Hope you’re well. I’d like to share a short article I wrote (published on May 15) making the case to immediately start planning for COVID-19 immunization delivery and suggesting activities to focus on now. The article focuses on India, but the core points and suggestions fo...
Dear All, I was recently asked to write an article about "getting ahead of the curve" in terms of capacitating the cold chain in anticipation of the Covid-19 vaccine and of course as the world starts to lift the lockdown, the imminent catch-up programs for routine vaccination programs . I would wel...
We have MR Vaccine for a campaign that had to be suspended due to current COVID-19 circumstances. These vaccines had been stored between minus 15 and minus 25 deg C at the Primary Store. Later, Vaccines were supplied to the District stores where they had been stored between plus 2 and 8 deg C. We w...
Dear Technet 21 Community, We are glad to share the Measles and Measles-Rubella (MR) Vaccine Five-dose vial presentations Facts sheet. This Facts Sheet informs of the availability of Measles vaccine and combined Measles-Rubella (MR) vaccine in both a 10-dose vial and a 5-dose vial presentations th...
Dear measles and rubella vaccine delivery and implementation experts, WHO is soliciting your expertise on the potential need and use for microarray patches (MAPs) (otherwise known as microneedles or microneedle patches) to deliver measles and rubella vaccines (MR), particularly in the context of ex...
What is the efficiency of Influenza vaccine?...
The recently published topic page on dose per container (DPC) provides a range of useful resources from case studies to decision support documents to better understand the effects of DPC on six immunization system components; namely operational costs, timely coverage, safety, wastage, and polic...
Hi All, If anyone has conducted a comprehensive vaccine wastage assessment, or knows anyone that has done so please send me a message on [email protected]. We are scouting for such expert for a 3 month assignment. Thanks....
Does anyone know how many countries in the AFRO region are using vaccine outside of the cold chain or using the controlled temperature chain?...
Dear all technet Members What should we do when the vaccine expiry date only shows the year and month but not the day ? For example: October 2019, can we use this vaccine until the end of October 2019 or do we have to use it before the first of October 2019. Thank Saleban yusuf...
Dear TechNet members, Bhutan is using Tetanus-Diphtheria (Td) during pregnancy. Guidelines provide clear instruction for women who have no record of previous Td vaccination and those who have received 3, 4 and 5 previous doses of Td containing vaccine. However, I could not find how many doses of Td...
Technet colleagues may be interested in this leader article in today's Times of London regarding the persistent ant-vaccination campaign. Please see this article: https://www.thetimes.co.uk/edition/comment/its-time-to-get-tough-with-anti-vaxxers-gq8prwcrv   Tom Lewis Remonsys Ltd, UK...
Dear TechNet colleagues, JSI in collaboration with SNTL Publishing and with support from Gavi the Vaccine Alliance are pleased to introduce to you Gaming Week! During the week of February 18th 2019, you will get a chance to play a System Design Game for Immunization Supply Chains which is based on ...
Dear colleagues, I am working on a new book project on VVM. I would like to include examples of the following and shall be grateful if you could kindly contact me. Your help is much appreciated! If you have any of the following, besides sending the material, I'd appreciate it if you could kindly ...
Hi TechNeters! It was brought to my attention by one of you that USC researchers have developed a new polio vaccine that doesn't require refrigeration. Check out here: https://news.usc.edu/151694/polio-vaccine-breakthrough-brings-researchers-closer-to-eliminating-disease-worldwide/ "By removing m...
Dear TechNet members, We would like to know the appropriate age for Td vaccine and whether what we are practising is right. As per the manufacturer’s leaflet (Serum Institute of India), Td vaccine is for primary vaccination and revaccination of children older than 7 years. However, in Bhutan, we ar...
Dear all,  Can any one explain how the decision is made as to which type of VVM is assigned to different vaccines, with examples? Are same vaccines manufactured by different manufactures assigned different type of VVM? Thanks,  Chandralal...
Dear All I am happy to share the information below regarding the UAV for Vaccine Delivery Project in Vanuatu:  Ministry of Health of the Republic of Vanuatu, assessed by UNICEF, invites you to join the pre-tender (kick-off) meeting for MoH project number S1721: "Transportation of Vaccines and Medi...
Most of the countries now have improved immunization coverages and reach more children with vaccination, but we still need to monitor the potency of vaccines that are given on top of the high coverages we have achieved in many countries. One of the biggest challenges when we talk about vaccine pot...
Here is a link to an interesting article that a colleague sent me: http://www.foxnews.com/health/2017/11/28/tens-thousands-dying-from-30b-fake-drugs-trade-who-says.html Basically, it reports on a study of the (potential) extent of damage from fake, adulterated or expired vaccines.  My question is m...
Dear Technet community users, we are looking into the acceptability of the heterologous prime-boost vaccination regimen. This is in the pipeline and would deliver similar antigens for a disease through different vaccine types in a defined sequence and interval to produce stronger immu...
Hello all, Microarray patches (MAPs) are under development for delivering vaccine into the skin. The technology has exciting potential for application to immunization programs. PATH is looking for input from experts in low- and middle-income country immunization programs about the feasibility of M...
Hello All, In the website for WHO PQ vaccines BCG and Yellow Fever are the two vaccines which have multi dose preparations packaged in ampoules. As soon as we open a mulit-dose ampoule and administer the first dose, we are leaving the remining doses in the ampoule exposed to environment (very often...
Hi all, I am quite new to the CTC adventure. After reading the second draft of the WHO CTC guideline, now ECTC (I also wen through the first version and the discussion in Langen and Ottawa), several questions came to my mind, and I would be extremely grateful if some of the forum members can help ...
PATH wants to better understand how immunization program managers, procurement officers, and other immunization experts view the tradeoffs between liquid and lyophilized presentations ofrotavirus vaccine for use in different settings. To gather feedback from those most knowledgeable about this topic...
Can any one help me that is there any VVM checking policy/guideline available with WHO in between receiving and dispatching of vaccines....
Dear colleagues, PATH is evaluating a new generation of needle-free jet injectors, known as disposable-syringe jet injectors (DSJIs),for vaccine deliveryin low and middle-income countries. We are writing to request your participation in a 15-minute survey https://www.surveymonkey.com/s/629RM3C as w...
Dear Colleagues : Please find attached an information bulletin which announces the recent WHO pre-qualification of DTwP-HepB-Hib vaccine available in a compact, pre-filled auto-disable injection technology (cPAD). An example of a compact pre-filled auto-disable injection technology is the Unijec...
About 2 decades back, a Director addressed the trainees and told – “in India we have many all India Problems but no all India solution for any single problem”. In surgical field – “intention of healing is always good often with unwanted scars, keloid and strictures”. In public health – as expresse...
Background: Rabies is a zoonotic disease and many vulnerable sections like rag pickers and municipality workers neglect animal bites due to ignorance of their potential deadly outcomes. Stray dogs abound in garbage pits and this population is exposed to their attacks. It should be a mandate for muni...
I was invited to attend the 14th day function of a funeral ceremony by my neighbor of a person who died at the age of 36 due to complications of “white Jaundice” (Hepatitis B Virus) in a tertiary care hospital. He married at the age of 32 to a lady of 24 years. They have one daughter of 9 months. Mo...
The budget impact of controlling wastage with smaller vials: A data driven model of session sizes in Bangladesh, India (Uttar Pradesh), Mozambique, and Uganda. W Yang, M Parisi, B Lahue, J Uddin, D Bishai - Vaccine, 2014 Link to full Article. http://www.sciencedirect.com/science/article/pii/S0264...
WHO and UNICEF have jointly prepared an information bulletin which addresses varied implications of different types of vaccine vial monitors (VVMs), notably VVM category type 7 (VVM7) and VVM category type 14 (VVM14), on vaccines such as the Inactivated Polio Vaccine (IPV) and the fully-liquid Dipht...
Cross-posted from the global.knowledge-gateway.org with thanks! Dear Friends, Could you please share this easy-to-digest message out to the West African public through your various means? It is very well done and provides people with the information they require to stop the spread of Ebola. An...
Many thanks to Umit Kartoglu for sharing these videos with the TechNet-21 forum! WHO/EPELA releases the most recently produced expert videos on VVM-based vaccine management. These videos are specifically produced for the new EPELA authentic e-learning course on vaccine vial monitor-based vaccine ...
Many thanks to Robert Steinglass for sharing this information with TechNet-21. As diseases emerge and infections re-emerge, new and improved vaccines are needed. The decisions about which vaccines should be developed first can affect millions of people's health, quality of life, and economic prog...
by Sy Gebrekidan (Merck), Debra Kristensen (PATH), Osman Mansoor (UNICEF), Gisele Corrêa Miranda (Fiocruz), Robert Steinglass (JSI), and Simona Zipursky (WHO) In 2009, the Vaccine Presentation and Packaging Advisory Group (VPPAG) published its first generic preferred product profile (gPPP) for ...
This article has been cross-posted from IVAC Blog with thanks! Lois Privor-Dumm MIBS, Director of Policy, Advocacy & Communications and Bruce Lee, Director of Operations Research at IVAC You are having 100 guests for an outdoor picnic and need to make the decision: do you buy big bottles ...
We would be interested in hearing the experience of national immunization programmes in countries that use the same vaccine but different presentations (eg. pentavalent 10 dose for fixed sites, pentavalent 1 dose for outreaches). - What issues and challenges have you had with such an arrangement...
by Daniel Thornton, GAVI; Henry Mwanyika, PATH; Drew Meek, WHO; Ulrike Kreysa, GS1 A project in Tanzania is exploring how best to implement barcodes on vaccine packaging. By adding barcodes to the shipping containers and secondary packaging used to transport vaccines, project organizers hope to l...
WHO and PATH have jointly updated the popular Temperature Stability of Vaccines slides that were originally produced by Dr. Julie Milstien for the TechNet21 2006 consultation. This updated version includes vaccines that have become available since the original slide set was created. The slides graph...
by Osman Mansoor, UNICEF, and Debra Kristensen, PATH As newer vaccines are introduced in low-income countries, immunization programs are facing difficult challenges related to proper storage, transport, tracking, and delivery of vaccines. While some of these challenges are not new, the importance o...
Cross-posted from the GAVI CSO forum with many thanks. As you may know, a United Nations Environment Programme treaty is currently being negotiated on mercury. A number of organizations have been working to ensure that the instrument does not restrict access to the vaccine preservative, thiomersa...
Dear colleagues, Here is a rather technical question: what to do with a "non freeze-sensitive" vaccine after exposure to freezing? The ultimate objective of my question is to refine and validate operational guidance for field workers. In the case of the "freeze-sensitive" v...
Cross-posted from the CDC website with thanks. In September 2011, CDC initiated a pilot project to test the implementation, using industry barcoding standards, of 2D barcodes on vaccine products. A 2D vaccine barcoding manufacturer's forum was conducted in January 2012 to inform manufacturers ...
An interview with Claire Dillavou, University of California, Los Angeles Earlier this year, Claire Dillavou of the University of California, Los Angeles was awarded $100,000 by the Bill & Melinda Gates Foundation through its Grand Challenges Explorations initiative*. Claire hopes to develop a...
by Cecily Stokes-Prindle and Lois Privor-Dumm, IVAC It sounds like a pretty mundane question, but the answer has major implications for delivering vaccines in low- and middle-income countries. Having consulted with experts from across the world, researchers at the International Vaccine Access Cen...
Hi All, After several years of working in Immunization related activities to help others, I find myself on the other side of the fence, with a 2 month old baby, in Senegal, trying to get her shots. She was born in the US, and we opted not do the HEP B at birth and figured to start at 2 months. We w...
The complete announcement is available at http://www.path.org/news/an120416-needlefree-devices.php. Call for needle-free intradermal delivery devices for upcoming clinical trial In collaboration with the Bill & Melinda Gates Foundation, PATH invites letters of interest and applications from tech...
Vac-4-All and MRTC Launch multi-centre Malaria Vaccine Efficacy Trial in Mali Vac-4-All, a new vaccine development initiative, and the Malaria Research and Training Centre (MRTC), a public research and training facility of the University of Bamako in the Republic of Mali, have completed ...
Questionnaire Regarding Measles Vaccine Vial Presentation Would a 5-dose vial of measles vaccine for routine immunization programs improve programme performance? We have received some reports that not all vaccination sessions include measles vaccination. Because the health workers are reluctan...
Many thanks to Alison Ruth Brunier for sharing this information Please note that we have today posted on the WHO web site an information sheet and questions and answers on thiomersal. - Information sheet - http://www.who.int/immunization/newsroom/thiomersal_information_sheet/en/index.html - ...
by Sophie Newland, PATH and Gisele Corrêa Miranda, Bio-Manguinhos/Fiocruz The environmental, social, and economic impact of packaging materials is a growing interest and concern among governments, industry, universities, and regulatory bodies around the world. Innovations in design and material d...
by Darin Zehrung, Jean-Marie Préaud, and Emily Griswold, PATH In an effort to advance the development of promising new rotavirus vaccine candidates, PATH is assisting manufacturers in Brazil, China, and India in the formulation, manufacturing, and clinical development of the vaccine candidates. T...
Rationale for introducing 5-dose vials of measles vaccine for routine immunization programs. Robert Steinglass of JSI/MCHIP challenges each of us to give our opinion on our preferences for measles vaccine vial size. At the just-completed Measles Partnership Annual Meeting at the American Red C...
This could become a reality if anti-thiomersal activists are successful . The United Nations Environment Programme (UNEP) is developing a treaty on the production, importation, and export of mercury-added products. Thiomersal (also known as thimerosal, mercurothiolate, and sodium 2-ethylmercurio...
To update the Multi-Dose Vial Policy, WHO and the Immunization Practices Advisory Committee (IPAC) has been designing a "visual cue". This is a small logo that will be placed on vaccine vials to allow health workers to judge whether to discard the vial at the end of a session, or allow the...
by Dmitri Davydov, UNICEF Supply Division and John Lloyd, PATH In partnership with the United Nations Children’s Fund (UNICEF), the Danish Technical University has begun a pro bono study on vaccine export packaging designs that would extend the safe, useful life of export packaging to allow for d...
by Drew Meek, WHO/QSS; Sheila Cattell, IFPMA; and Joanie Robertson, PATH In the packaged food and consumer products industries, barcodes have become a way of life. Most large supermarkets around the world use barcode scanners at the checkout counter, and an average smartphone can now scan barcode...
Optimizing presentation and packaging for HPV vaccinesby Debbie Kristensen and D. Scott LaMontagne, PATH Working in collaboration with the Vaccine Presentation and Packaging Advisory Group (VPPAG), representatives from the public health community have initiated a series of studies to guide presentat...
The vaccine programme has become more complicated in the last few years, and more vaccines that have to be reconstituted have become commonplace in health facility fridges. At the same time, other programmes have increased the reach of their interventions to health facilities, and several therapeuti...
by Simona Zipursky, PATH; Christoph Conrad, WHO/Quality, Safety & Standards; Tony Richardson, CDC/Vaccine Supply & Assurance Branch They call it the Decade of Vaccines for a reason. More new vaccines will become available between 2010 and 2020 than all previous decades combined. Not onl...
Project Optimize is seeking real-life stories of how vaccine vial monitors are making an impact in the field. If you would like to share your story, please reply to this forum post. Dont hesitate to also post photographs if you have some Thanks in advance Michel Zaffran...
China considers VVMs by Qiyou Xiao, China National Biotec Group; Shuyan Zuo, WHO China; and Jack Zhang, PATH China In June, the first national seminar and information session about the necessity and feasibility of using vaccine vial monitors (VVMs) on domestically produced vaccines used in China w...
WHO develops a process to determine programmatic suitability of vaccines for prequalificationby Rudi Eggers, WHO/EPI, and Nora Dellepiane, WHO/QSS The World Health Organization (WHO) recently convened a working group to propose a new process for assessing the programmatic suitability of vaccines for...
Dear Colleagues, PATH is pleased to share with you key findings on the technical and commercial feasibility of stabilizing vaccines. These findings are outlined in a recent guest editorial published in the journal Human Vaccines. In the editorial, PATH's Debra Kristensen, group leader of Vaccin...
  • Page :
  • 1
  • 2
  • 3
There are no discussions available here currently